Influence of vitamin D receptor gene polymorphisms on treatment of chronic HCV patients with interferon

Evaluation of the correlation between vitamin D receptor polymorphism and the response to treatment in chronic hepatitis C patients

Relation between Osteopontin gene polymorphism & its protein level and the efficacy of interferon-based therapies in HCV patients

Evaluation of vitamin D receptor gene polymorphism and serum 25-hydroxy vitamin d level in patients with hepatocellular carcinoma

Interleukin 10 and 12 polymorphisms and their association with treatment outcome of patients with chronic hepatitis C infection

Osteopontin gene polymorphism as marker predicting the efficacy of interferon-based therapies in patients with chronic hepatitis C

Relation between interleukin-10 polymorphism and the efficacy of interferone–based therapies in HCV patients

Effect of vitamin D supplementation on end treatment response to peginterferon alfa-2b/ribavirin combination in chronic hepatitis c genotype 4

Interleukin 28b polymorphisms and therapy response in chronic hepatitis C patients

Single nucleotide polymorphism of IL-10 and IL- 28b as predictors to the response of interferon therapy in HCV infected children